Yoshiaki Usui

695 total citations
22 papers, 119 citations indexed

About

Yoshiaki Usui is a scholar working on Hematology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Yoshiaki Usui has authored 22 papers receiving a total of 119 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 8 papers in Pathology and Forensic Medicine and 7 papers in Molecular Biology. Recurrent topics in Yoshiaki Usui's work include Multiple Myeloma Research and Treatments (7 papers), Lymphoma Diagnosis and Treatment (6 papers) and Acute Lymphoblastic Leukemia research (4 papers). Yoshiaki Usui is often cited by papers focused on Multiple Myeloma Research and Treatments (7 papers), Lymphoma Diagnosis and Treatment (6 papers) and Acute Lymphoblastic Leukemia research (4 papers). Yoshiaki Usui collaborates with scholars based in Japan, United States and Netherlands. Yoshiaki Usui's co-authors include Masami Takeuchi, Kosei Matsue, Kentaro Narita, Manabu Fujisawa, Kota Fukumoto, Yasuhito Suehara, Keitaro Matsuo, Yoshiaki Abe, Yoshinobu Maeda and Hidemi Ito and has published in prestigious journals such as Blood, International Journal of Cancer and Oncotarget.

In The Last Decade

Yoshiaki Usui

21 papers receiving 118 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yoshiaki Usui Japan	7	51	42	38	36	20	22	119
Simona Sammassimo Italy	7	70 1.4×	55 1.3×	27 0.7×	79 2.2×	31 1.6×	26	158
Yasufumi Kawasaki Japan	9	93 1.8×	36 0.9×	34 0.9×	33 0.9×	36 1.8×	19	173
Pallavi Galera United States	6	53 1.0×	51 1.2×	20 0.5×	75 2.1×	33 1.6×	13	153
Mathieu Simonin France	9	47 0.9×	38 0.9×	56 1.5×	37 1.0×	19 0.9×	27	182
Asu Fergün Yılmaz Türkiye	5	103 2.0×	22 0.5×	22 0.6×	32 0.9×	40 2.0×	20	147
Andrei Coliţă Romania	7	90 1.8×	30 0.7×	31 0.8×	24 0.7×	54 2.7×	38	153
Nicola Cantore Italy	9	84 1.6×	32 0.8×	43 1.1×	41 1.1×	44 2.2×	14	158
Jun Amaki Japan	6	42 0.8×	64 1.5×	23 0.6×	98 2.7×	22 1.1×	19	154
Kento Umino Japan	8	65 1.3×	41 1.0×	35 0.9×	31 0.9×	32 1.6×	23	148
Kalman Filanovsky Israel	6	125 2.5×	41 1.0×	38 1.0×	36 1.0×	44 2.2×	21	192

Countries citing papers authored by Yoshiaki Usui

Since Specialization

Citations

This map shows the geographic impact of Yoshiaki Usui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshiaki Usui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshiaki Usui more than expected).

Fields of papers citing papers by Yoshiaki Usui

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshiaki Usui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshiaki Usui. The network helps show where Yoshiaki Usui may publish in the future.

Co-authorship network of co-authors of Yoshiaki Usui

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshiaki Usui. A scholar is included among the top collaborators of Yoshiaki Usui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshiaki Usui. Yoshiaki Usui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Usui, Yoshiaki, Mikiko Endo, Yusuke Iwasaki, et al.. (2025). Clinical Significance of TP53 -Mutant Clonal Hematopoiesis Across Diseases. Blood Cancer Discovery. 6(4). 298–306.

Endo, Mikiko, Yoshiaki Usui, Yusuke Iwasaki, et al.. (2024). Germline Susceptibility to Renal Cell Carcinoma and Implications for Genetic Screening. JCO Precision Oncology. 8(8). e2400094–e2400094. 1 indexed citations

Usui, Yoshiaki, Hidemi Ito, Kota Katanoda, et al.. (2023). Trends in non‐Hodgkin lymphoma mortality rate in Japan and the United States: A population‐based study. Cancer Science. 114(10). 4073–4080. 8 indexed citations

Usui, Yoshiaki & Yukihide Momozawa. (2023). Personalized medicine with germline pathogenic variants: Importance of population‐ and region‐wide evidence. Cancer Science. 114(10). 3816–3824. 3 indexed citations

Shimomura, Yoshimitsu, Akihito Shinohara, Shohei Mizuno, et al.. (2023). Fludarabine plus reduced-intensity busulfan versus fludarabine plus myeloablative busulfan in patients with non-Hodgkin lymphoma undergoing allogeneic hematopoietic cell transplantation. Annals of Hematology. 102(3). 651–661. 1 indexed citations

Usui, Yoshiaki, Yusuke Iwasaki, Keitaro Matsuo, et al.. (2022). Association between germline pathogenic variants in cancer‐predisposing genes and lymphoma risk. Cancer Science. 113(11). 3972–3979. 8 indexed citations

Fujii, Nobuharu, Yuichiro Nawa, Yuki Fujiwara, et al.. (2022). Possible prognostic impact of WT1 mRNA expression at day + 30 after haploidentical peripheral blood stem cell transplantation with posttransplant cyclophosphamide for patients with myeloid neoplasm: a multicenter study from the Okayama Hematological Study Group. International Journal of Hematology. 115(4). 515–524. 1 indexed citations

Fujii, Nobuharu, Yoshiaki Usui, Akira Yamamoto, et al.. (2022). Association between early corticosteroid administration and long-term survival in non-infectious pulmonary complications after allogeneic hematopoietic stem cell transplantation. International Journal of Hematology. 117(4). 578–589. 1 indexed citations

Usui, Yoshiaki, Hidemi Ito, Yuriko N. Koyanagi, et al.. (2020). Changing trend in mortality rate of multiple myeloma after introduction of novel agents: A population‐based study. International Journal of Cancer. 147(11). 3102–3109. 13 indexed citations

10.

Usui, Yoshiaki, Hidemi Ito, Yumiko Kasugai, et al.. (2019). Helicobacter pylori (HP) infection alone, but not HP-induced atrophic gastritis, increases the risk of gastric lymphoma: a case-control study in Japan. Annals of Hematology. 98(8). 1981–1987. 11 indexed citations

11.

Abe, Yoshiaki, Tetsuya Kobayashi, Yoshiaki Usui, et al.. (2019). N-terminal pro-brain natriuretic peptide reflects both left ventricular diastolic dysfunction and myeloma-related renal insufficiency and robustly predicts mortality in patients with symptomatic multiple myeloma. Oncotarget. 10(10). 1160–1170. 2 indexed citations

12.

Abe, Yoshiaki, Akihiro Kitadate, Yoshiaki Usui, et al.. (2019). Diagnostic and Prognostic Value of Using 18F-FDG PET/CT for the Evaluation of Bone Marrow Involvement in Peripheral T-Cell Lymphoma. Clinical Nuclear Medicine. 44(5). e336–e341. 19 indexed citations

13.

Matsuoka, Ken‐ichi, Maiko Sakamoto, Yoshiaki Usui, et al.. (2019). Salvage Haploidentical Transplantation Using Low-dose ATG for Early Disease Relapse after First Allogeneic Transplantation: A Retrospective Single-center Review.. PubMed. 73(2). 161–171. 1 indexed citations

14.

Abe, Yoshiaki, Yoshiaki Usui, Kentaro Narita, Masami Takeuchi, & Kosei Matsue. (2018). Concomitant subcutaneous intravascular lymphoma lesions in a patient with cardiac diffuse large B-cell lymphoma: is intravascular lymphoma a distinct clinical entity?. International Journal of Hematology. 108(6). 637–639. 4 indexed citations

15.

Abe, Yoshiaki, Manabu Fujisawa, Yoshiaki Usui, et al.. (2017). Prevalence and Prognostic Impact of Cytogenetic Abnormalities in 220 Patients With Multiple Myeloma. Clinical Lymphoma Myeloma & Leukemia. 17(1). e29–e29. 1 indexed citations

16.

Abe, Yoshiaki, Yoshiaki Usui, Kentaro Narita, Masami Takeuchi, & Kosei Matsue. (2016). Clinical Features, Diagnosis, and Prognosis of 14 Cases of Neurolymphomatosis: Single Institutional Experience over 10 Years. Blood. 128(22). 3042–3042. 3 indexed citations

17.

Fukumoto, Kota, Manabu Fujisawa, Yasuhito Suehara, et al.. (2016). Prognostic impact of immunophenotypic complete response in patients with multiple myeloma achieving better than complete response. Leukemia & lymphoma. 57(8). 1786–1792. 15 indexed citations

18.

Matsue, Kosei, Yuya Matsue, Yoshiaki Usui, et al.. (2016). Quantification of bone marrow plasma cell infiltration in multiple myeloma: usefulness of bone marrow aspirate clot with CD138 immunohistochemistry. Hematological Oncology. 35(3). 323–328. 20 indexed citations

19.

Suehara, Yasuhito, Hiroyuki Takamatsu, Kota Fukumoto, et al.. (2016). Abnormal heavy/light chain ratio after treatment is associated with shorter survival in patients with IgA myeloma. Cancer Science. 108(2). 187–192. 4 indexed citations

20.

Fujisawa, Manabu, Yasuhito Suehara, Kota Fukumoto, et al.. (2015). Clinical Significance of Circulating Plasma Cells in Myeloma: Multiparameter Flow Cytometric Analysis. Blood. 126(23). 5352–5352. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact